1. Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis
- Author
-
Lan, Zhiyi, Ahmad, Nafees, Baghaei, Parvaneh, Barkane, Linda, Benedetti, Andrea, Brode, Sarah K, Brust, James C M, Campbell, Jonathon R, Chang, Vicky Wai Lai, Falzon, Dennis, Guglielmetti, Lorenzo, Isaakidis, Petros, Kempker, Russell R, Kipiani, Maia, Kuksa, Liga, Lange, Christoph, Laniado-Laborín, Rafael, Nahid, Payam, Rodrigues, Denise, Singla, Rupak, Udwadia, Zarir F, Menzies, Dick, Ahmad, N, Baghaei, P, Barkane, L, Benedetti, A, Brode, SK, Brust, JCM, Campbell, JR, Chang, VWL, Falzon, D, Guglielmetti, L, Isaakidis, P, Kempker, RR, Kipiani, M, Kuksa, L, Lan, Z, Lange, C, Laniado-Laborín, R, Nahid, P, Rodrigues, D, Singla, R, Udwadia, ZF, and Menzies, D
- Abstract
Treatment of multidrug-resistant tuberculosis requires long-term therapy with a combination of multiple second-line drugs. These drugs are associated with numerous adverse events that can cause severe morbidity, such as deafness, and in some instances can lead to death. Our aim was to estimate the absolute and relative frequency of adverse events associated with different tuberculosis drugs to provide useful information for clinicians and tuberculosis programmes in selecting optimal treatment regimens.
- Published
- 2020
- Full Text
- View/download PDF